Family history of colorectal cancer in first-degree relatives and metachronous colorectal adenoma
File(s)
Author(s)
Type
Journal Article
Abstract
OBJECTIVES
Little is known about the relationship between having a first-degree relative (FDR) with colorectal cancer (CRC) and risk for metachronous colorectal adenoma (CRA) following polypectomy.
METHODS
We pooled data from seven prospective studies of 7697 patients with previously resected CRAs to quantify the relationship between having a FDR with CRC and risk for metachronous adenoma.
RESULTS
Compared with having no family history of CRC, a positive family history in any FDR was significantly associated with increased odds of developing any metachronous CRA (OR = 1.14; 95% CI = 1.01–1.29). Higher odds of CRA were observed among individuals with an affected mother (OR = 1.27; 95% CI = 1.05–1.53) or sibling (OR = 1.34; 95% CI = 1.11–1.62) as compared with those without, whereas no association was shown for individuals with an affected father. Odds of having a metachronous CRA increased with number of affected FDRs, with ORs (95% CIs) of 1.07 (0.93–1.23) for one relative and 1.39 (1.02–1.91) for two or more. Younger age of diagnosis of a sibling was associated with higher odds of metachronous CRA, with ORs (95% CIs) of 1.66 (1.08–2.56) for diagnosis at <54 years; 1.34 (0.89–2.03) for 55–64 years; and 1.10 (0.70–1.72) for >65 years (p-trend = 0.008). Although limited by sample size, results for advanced metachronous CRA were similar to those for any metachronous CRA.
CONCLUSIONS
A family history of CRC is related to a modestly increased odds of metachronous CRA. Future research should explore whether having a FDR with CRC, particularly at a young age, should have a role in risk stratification for surveillance colonoscopy.
Little is known about the relationship between having a first-degree relative (FDR) with colorectal cancer (CRC) and risk for metachronous colorectal adenoma (CRA) following polypectomy.
METHODS
We pooled data from seven prospective studies of 7697 patients with previously resected CRAs to quantify the relationship between having a FDR with CRC and risk for metachronous adenoma.
RESULTS
Compared with having no family history of CRC, a positive family history in any FDR was significantly associated with increased odds of developing any metachronous CRA (OR = 1.14; 95% CI = 1.01–1.29). Higher odds of CRA were observed among individuals with an affected mother (OR = 1.27; 95% CI = 1.05–1.53) or sibling (OR = 1.34; 95% CI = 1.11–1.62) as compared with those without, whereas no association was shown for individuals with an affected father. Odds of having a metachronous CRA increased with number of affected FDRs, with ORs (95% CIs) of 1.07 (0.93–1.23) for one relative and 1.39 (1.02–1.91) for two or more. Younger age of diagnosis of a sibling was associated with higher odds of metachronous CRA, with ORs (95% CIs) of 1.66 (1.08–2.56) for diagnosis at <54 years; 1.34 (0.89–2.03) for 55–64 years; and 1.10 (0.70–1.72) for >65 years (p-trend = 0.008). Although limited by sample size, results for advanced metachronous CRA were similar to those for any metachronous CRA.
CONCLUSIONS
A family history of CRC is related to a modestly increased odds of metachronous CRA. Future research should explore whether having a FDR with CRC, particularly at a young age, should have a role in risk stratification for surveillance colonoscopy.
Date Issued
2018-06-06
Date Acceptance
2017-12-07
Citation
American Journal of Gastroenterology, 2018, 113, pp.899-905
ISSN
1572-0241
Publisher
Nature Publishing Group
Start Page
899
End Page
905
Journal / Book Title
American Journal of Gastroenterology
Volume
113
Copyright Statement
© 2018 The American College of Gastroenterology
Subjects
1103 Clinical Sciences
Gastroenterology & Hepatology
Publication Status
Published
Date Publish Online
2018-02-20